Amgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after it was turned down by the regulator because of safety concerns. The agency approved Evenity (romosozumab ...

THE PLACER COUNTY SHERIFF’S OFFICE IS STILL INVESTIGATING THIS CASE, A Human remains found more than three decades ago in Placer County have been identified as belonging to a Berkeley woman who ...

which we are involved in a co-licensing agreement with Amgen. Can partnering ensure future success for pharma? UCB is very receptive to outside engagement. There is a real understanding within the ...

After hours: 7 February at 7:07:51 pm GMT-5 ...

* EPS estimates are Normalized unless otherwise noted.

Those looking for an FPGA prototype of Rocket Chip should checkout SiFive’s Freedom platform. Those looking for an FPGA-accelerated simulation environment (for obtaining cycle-accurate performance ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Objective CONCERTO was a randomised, double-blind, parallel-armed study of methotrexate (MTX) in combination with adalimumab to assess whether an increasing trend of efficacy and decreased safety ...

The following are some global research internship positions: ...